Top 50 Medical Device VC Funds in Asia

Investor	Medical Device Asia investments
Cowin Capital	11
Qiming Venture Partners	11
Sequoia Capital China	11
CD Capital	9
Haibang Capital	8
Lilly Asia Ventures	8
BioTrack Capital	7
IDG Capital	7
Nippon Venture Capital	6
Legend Capital	6
Addor Capital	6
Marathon Venture Partners	5
Nissay Capital	5
BioVenture	5
Shunwei Capital	5
Sunland Fund	5
SZHTI Group	5
Dalton Venture	5
Med-Fine Capital	5
Qiaojing Capital	4
Frees Fund	4
Fortune Venture Capital	4
SND Ventures Group	4
Prox Ventures	4
Oriza Holdings	4
UTokyo Innovation Platform	4
Taiyu Investment	4
Share Capital	4
Taiyu Investment	4
Mitsubishi UFJ Capital	4
Chiron Ventures	3
Oriental Fortune Capital	3
Northern Light Venture Capital	3
Apricot Capital	3
Shenzhen Capital Group	3
Highlight Capital	3
Jinding Capital	3
Cenova	3
Volcanics Venture	3
SBI Investment	3
Keio Innovation Initiative	3
Qingrong Ventures	3
Yuanhui Chuangyi	3
BGI Co-Win	3
Redhill Capital	3
EFung Capital	3
Insight Capital	3
Prosperico Ventures	3
Source Code Capital	3
Huagai Capital	3

Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.

Investment focus

Manufacturing, Health Care, Software
Series A, Series B, Angel
China, Hong Kong, United States

Portfolio highlights

Shengrong Technology — Shengrong Technology is a lithium replenishment technology company that specializes in the development, manufacturing, and production of lithium replenishment materials for use in battery cathodes.
Shifan Microelectronics — Shifan Microelectronics offers intelligent display SOC chip design and development services. Shifan Microelectronics is primarily concerned with the research and development of display processing and device technologies.
Chengling Microelectronics — Chengling Microelectronics is a company that produces high-performance power management chips. It is primarily involved in the research & development, design, manufacturing, and selling of high-performance power management chips. Its product applications include server and notebook computer power supplies, new energy inverter systems, andautomotive electronics. Chengling Microelectronics focuses on cutting-edge power management chip technology and leverages local industry chain resources to meet mid-to-high-end power management product demands.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Ruining Bio — Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection, wound repair, tumor embolization, and anti-tumor drugs. Ruining Bio brings together various professionals in materials, chemistry, biomedical engineering, and clinical medicine.
Hope Medicine — Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases.
Silicon Yi Technology — Silicon Yi Technology is an RNA nano-pesticide research and development firm.

We help founders build enduring companies.

Investment focus

Biotechnology, Health Care, Software
Series A, Series B, Series C
China, United States, Australia

Portfolio highlights

Black Jade Star Rock — Black Jade Star Rock develops organoid-based intelligent equipment and chips. It is a biomedical research and development company with organoid science as its fundamental technology.
Moonshot AI — Dark Side of the Moon is an AI large-scale model company.
Membrane Biofilm Technology — Membrane Biofilm Technology is a membrane filtration company that specializes in the development, production, and solutions of membrane filtration products.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Angel
China, United States

Portfolio highlights

Kanova — Kanova is a biopharmaceutical firm.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.

Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Angel, Series B
China

Portfolio highlights

MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
Targeting One — Targeting One is an in-vitro diagnostic product developer.
Comanche Biopharma — Comanche Biopharma is a biopharmaceutical company that develops siRNA therapy for the treatment of preeclampsia. The company aims to lower the risks of pregnancy and prematurity by safely sustaining natural pregnancy and allowing fetal maturation.

BioTrack Capital is a China-based investment firm.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Singapore

Portfolio highlights

Acchrom Tech — Huapu Instrument (Beijing) Technology Co., Ltd. is committed to building Huapu into a well-known national brand in the field of chromatography, and is an enterprise that provides the overall solution of "product + technical service" in the field of chromatography. The company formulates differentiated marketing strategies, builds anationwide marketing team centered on key provinces, and builds a professional and efficient marketing network.
Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Qitan Technology — Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenientinstrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.

IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.

Investment focus

Software, Internet, E-Commerce
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Ultiverse — Ultiverse builds the social gaming metaverse, connecting the Web3 to an immersive, fully VR compatible virtual world, and finally creates a unique MetaFi.
B² Network — B² Network is a Bitcoin Layer 2 network that utilizes ZK rollup and on-chain logical gate commitment verification mechanisms. It is a supplementary network that runs on top of the Bitcoin Network. It also introduces smart contracts to Bitcoin, which could open up new possibilities for DeFi, NFTs, and derivatives.
Novaserene Entertainment — Yuanyi Entertainment is an AI open-world game company dedicated on incorporating AI into game development. It is creating an AI-powered open world shooting game with the UE5 engine.

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Investment focus

Software, Health Care, Information Technology
Funding Round, Series A, Seed
Japan, United States

Portfolio highlights

Issues — Issues provides development and management of web service issues that solve the problems.
Trustart — Trustart engages in real estate research business and real estate big data provision. The company offers real estate big data and big data subscriptions.
LIFESCAPES — LIFESCAPES is a research and manufacturer of brain-computer interface equipment.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

MS Energy — MS Energy is a technology-driven enterprise that specializes in providing green energy solutions.
Dearer Medical — Dearer Medical is a medical device company that specializes in the development, production, and sales of eye-related medical products such as color contact lenses.
Zhongke Guosheng — Zhongke Guosheng is a bio-based materials R&D firm that designs and develops furan-based bio-based materials.

Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.

Investment focus

Manufacturing, Electronics, Medical
Series A, Series B, Funding Round
China, Hong Kong, United States

Portfolio highlights

Wanhua Electronics — Wanhua Electronics is a provider of electronic materials that specializes in the research and development of electronic special gas products. It is a subsidiary of Wanhua Energy Saving Technology Group.
Zhongji New Materials — Zhongji New Materials is a high-tech company focused on technology research. It produces precision grinding and polishing products.
MeeYear Intelligent Technology — Mingyi Technology is a compant that manufactures precision parts and automation equipment, including stamping molds, stamping production, embedded injection molding production, injection molding production, and intelligent automation equipment.

Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Angel
China, Hong Kong, United States

Portfolio highlights

Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
Neowise — XinjingZhiyuan is an immune cell therapy company focusing on solid tumors.

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Investment focus

Health Care, Internet, Medical
Funding Round, Seed, Series A
Japan, United States

Portfolio highlights

Dodai — Dodai manufactures and assembles the electric motorcycles.
Yap — Yap helps pharmaceutical businesses enter the market in a multitude of methods.
Pocket Sign — Pocket Sign develops digital platforms that store e-signatures and other authentication details for it's users privacy and security.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.

Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.Shunwei Capital is a China-based company that was founded in 2011 by Tuck Lye Koh and Lei Jun.

Investment focus

Manufacturing, Internet, E-Commerce
Series A, Series B, Series C
China, India, United States

Portfolio highlights

Xreal — Nreal is the developer of ready-to-wear mixed reality glasses. Its flagship product, Nreal light, is the first lightweight and comfortable mixed reality glasses, sporting a vivid display combined with spatial computing algorithms for an immersive experience. The company aims to make mixed reality available and accessible to everyone. They strive torealize the full potential of mixed reality by empowering developers to create applications that can ultimately propel a new era of entertainment, productivity, and more.Nreal was founded in 2017 and is based in Beijing, China.
Neurodome — Neurodome is a manufacturer of non-invasive deep brain nerve modulation technology. It focuses on the research and development of non-invasive deep brain nerve modulation products.
Zhice Technology — Zhice Technology is a high-tech corporation specializing in industrial big data and artificial intelligence. It is committed to developing a new generation of data intelligence platforms and offers industrial organizations data intelligence solutions that have been tested by real-world businesses.

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China

Portfolio highlights

Precedo Biomedical — Precedo Biomedical is a high-tech business that specializes in industrial safety & national strategic biosafety through core cell engineering technologies. It employs the innovation-driven development approach, which leverages scientific and technological innovation to propel industrial innovation, to conduct industrialization and scientificresearch centered on "cell" issues that impede biomedical development.
Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
Juhe Biotechnology — Juhe Biotechnology is a company that creates early detection tools for gynecological malignancies.

SZHTI Group is a company that provides asset management and financing services.

Investment focus

Manufacturing, Electronics, Health Care
Series A, Angel, Funding Round
China, United States

Portfolio highlights

Booster tech — Booster tech specializes in factory testing and automation equipment R&D, processing, sales, and servicing. It specializes in the design and delivery of test measurement and automation equipment and systems in the electronics industry, offering automation solutions, visual test solutions, acoustic test solutions, radio frequency test solutions,Automotive electronics and autonomous driving test solutions, ODM and standard electronic modules, and other products and solutions.
Nair Electronics — Nair Electronics is a domestic aviation sensor company that develops and owns fundamental technical competencies such as proprietary piezoelectric ceramic formulations and MEMS chip design.
Olight Technology — OLIGHT's Official Website. We are a global technology-driven lighting company filled with dedicated people who want to provide the best for our customers.

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Seed
China

Portfolio highlights

MacroLux — MacroLux operates as a medical technology company focusing on endoscopic interventional business. MacroLux develops endoscopic interventional therapy solutions and promote them to the majority of medical customers.
Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Jingqin Intelligent Manufacturing — Jingqin Intelligent Manufacturing is an innovative technology company that specializes in developing surgical instruments in the medical field.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States

Portfolio highlights

Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
Leadinno Medical Valley — Leadino Medical Valley is a producer of medical devices for neuroregulatory functions.

Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.

Investment focus

Health Care, Medical, Medical Device
Series A, Series B, Angel
China

Portfolio highlights

Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.

By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.

Investment focus

Artificial Intelligence, Biotechnology, Medical
Series A, Seed, Angel
China, United States, Singapore

Portfolio highlights

Aeroband — Aeroband is a manufacturer of air paddles and other musical instruments.
Brix — Brix is an AI-based platform that offers online recruiting services and solutions.
Babel AI — Babel AI offers users full-process AI services for software development, operation, and maintenance. Its objective is to increase software development efficiency by recreating automated and visible AI-generated software workflows and software operating environments.

Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.

Investment focus

Manufacturing, Information Technology, Health Care
Series A, Series B, Series C
China, Japan, United States

Portfolio highlights

AIsphere — AIsphere focuses on visual multimodal large models and empowering content producers in many sectors and scenarios with AIGC technology.
EurekaBio — EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
Yixian Intelligence — Yixian Technology is a developer of cutting-edge driving training services, including robot coaches. Yixian Technology is also involved in core technology research, including augmented reality, intelligent ubiquitous perception, robot mechanics, cognitive behavior, and intelligent voice interaction based on artificial intelligence and big data.

SND Ventures Group is a venture capital and private equity firm specializing in seed investments.

Investment focus

Health Care, Manufacturing, Medical
Series A, Series B, Angel
China

Portfolio highlights

Vende — Vende is a digital technology company that provides AI data processing, big data, cloud data, and enterprise software services.
Forvision — Forvision focuses on low-speed autonomous driving and is committed to implementing the most advanced intelligent driving technologies.
Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Funding Round, Seed, Series A
China, United States, United Kingdom

Portfolio highlights

VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments

Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.

Investment focus

Health Care, Manufacturing, Biotechnology
Series A, Series B, Series C
China, United States, Canada

Portfolio highlights

Neurodome — Neurodome is a manufacturer of non-invasive deep brain nerve modulation technology. It focuses on the research and development of non-invasive deep brain nerve modulation products.
BMSer Technoogy — Hangzhou Xieneng Technology Co., Ltd. (stock code: 836506) , having the core technology of independent intellectual property rights ,is a high-tech enterprise that specialized in new energy battery management technology research and development, production and management. The company was founded in May 2012, and the registered capital is13 million 500 thousand yuan RMB. It is located in Xihu District Zhejiang science and technology industry building in Hangzhou, Zhejiang Province, and is subordinate to the national high and new development zone. It has been founded by several overseas returnees, and has been invested by well-known investment institutions in China. The company adheres to the management concept of "first-class technology, quality first, green energy and benefit human", and is committed to providing battery management and maintenance solutions for customers. Relying on independent intellectual property rights and innovation mechanism, it has applied for invention patents 19, utility model patents 22 and software copyright 24. The company is based on self developed power integration chip and consistency. The battery active balance management system has the characteristics of reasonable design, novel structure, excellent performance and convenient installation and maintenance, and has reached the leading and international advanced level in China. By adhering to the spirit of "innovation, concentration, openness and tolerance", coeng technology has condensed a number of excellent R & D personnel and market management elite, and established an overseas R & D institution in the Silicon Valley of the United States. With innovative technology and advanced project management experience, the company provides customers with first class and most valuable products and services. At present, the company has more than 10 models of three series battery management systems, such as electric vehicles, scenery and storage, backup power supply, and many large professional battery manufacturers and electric vehicle manufacturers in China. Home, micro grid photovoltaic enterprises and national appliance network companies and other enterprises have formed extensive market cooperation relationship.
Zhongji New Materials — Zhongji New Materials is a high-tech company focused on technology research. It produces precision grinding and polishing products.

The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.

Investment focus

Biotechnology, Medical, Health Care
Series A, Funding Round, Seed
Japan, United States, United Kingdom

Portfolio highlights

Heartseed — Heartseed has set a mission to “open the door to heart disease treatment with regenerative medicine” and is working toward the day-to-day clinical application of myocardial regenerative medicine.
Yoii Fuel — Yoii Fuel is a software company which analyzes a company's KPIs and enables them to obtain a means of financing based on this data.
Better Place — Better place vision is to create a world in which kind people can continue to be kind, as well as a society in which people can work in their own way without worrying about money.

Taiyu Investment is an investment firm.

Investment focus

Medical, Health Care, Biotechnology
Series A, Seed, Angel
China

Portfolio highlights

Immorna — Immorna specializes in the production of RNA-based therapeutics.
ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.

Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Angel
China, United States, Colombia

Portfolio highlights

Depp CNC — Depp CNC is a research and development manufacturer of CNC machine tools and core accessories.
Microview — Microview is a high-tech enterprise specializing in the research and development of high-precision complex process chip packaging equipment.
Jodell Robotics — Jodell develops intelligent robotic equipment designed to serve in automotive and logistics industries.

Taiyu Investment is an investment firm.

Investment focus

Medical, Health Care, Medical Device
Series A
China

Portfolio highlights

LeadBio Tech — LeadBio Tech is a biotechnology company that specializes in the development of bioartificial blood vessel medical devices.
Juzheng Medical — Juzheng Medical develops medical device products, specializing in the study, creation, and manufacturing of medical devices. It is committed to providing innovative medical devices for vascular interventional treatments.
Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Investment focus

Information Technology, Software, Health Care
Funding Round, Series B, Series A
Japan, United States, China

Portfolio highlights

Parallel — Parallel Inc. develops a parallel SNS which can be used while playing games on smartphones.
Swell — Swell is an information technology company that specializes in providing web and digital platforms.
GenerativeX Co — GenerativeX provides AI app development, consulting, and generative model development.

Chiron Ventures is an investment firm specializes in innovation and investment in medical health.Chiron Ventures has accumulated rich experience and resources in medical technology development, medical innovation and entrepreneurship, and medical market development, providing substantial support and professional value-added services for itsinvestment projects.

Investment focus

Health Care, Medical, Medical Device
Series A, Seed, Angel
China, Australia, United States

Portfolio highlights

Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
Ren Labs — Empowering projects to create a limitless future for the decentralized web.
Pulnovo Medical — Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Information Technology, Manufacturing
Series A, Series B, Seed
China, United States

Portfolio highlights

Renshuo Solar — Renshuo Solar is a manufacturer of perovskite tandem solar panels.
Leen Automation — Leen Automation is an automation technology company that focuses on the development and manufacturing of servo drives and motors.
Yihua New Energy — Yihua New Energy manufactures bipolar sodium-ion batteries designed based on low-cost solid electrolyte materials.

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Seed
China, United States, South Korea

Portfolio highlights

Sanegene Bio — Sanegene Bio is currently operating in stealth mode.
Wuwen Xinqiong — Wuwen Core Dome is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.
Zhonghui Laser — Zhonghui Laser is an emerging technology company dedicated to the development and manufacture of advanced lasers.

Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.

Investment focus

Health Care, Medical Device, Medical
Series A, Series B, Series C
China

Portfolio highlights

Axiata — Axiata Bio is a R&D and manufacturer of biomedical consumables.
Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
Yiteng Medical — Yiteng Medical manufactures medical devices. The business's basic products are medical CT tubes and industrial CT microfocus X-ray tubes.

Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation and emerging industriesdeveloping. SCGC has registered capital of 5.42 billion RMB, andtotal AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based of the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide.

Investment focus

Manufacturing, Health Care, Software
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Petlibro — We believe that pets deserve responsible, high-quality care--and that their humans deserve an easier way to offer this to them. We offer seamless designs that allow human and animal habits to perfectly meld into one co-existing routine, creating a little more happiness for owners & pets every day.
Salus BioMed — Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology and spatial omics products.
Sanegene Bio — Sanegene Bio is currently operating in stealth mode.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Series C
China, United States, Portugal

Portfolio highlights

Aoli Biotechnology — Aoli Biotechnology is a biopharmaceutical oral delivery technology provider. Aoli Biotechnology focuses on research into macromolecule oral delivery technology and has developed a number of world-leading excipient technology patents, including soteria and phloral technology.
Hydropeng Technology — Hydropeng Technology is a company that developes solid oxide fuel cell specializes in the engineering development of solid oxide fuel cells (SOFC) and electrolytic cells (SOEC). Hydropeng Technology applies its extensive R&D capabilities in materials, chemistry, mechanics, and other fields to create efficient hydrogen energy systems thatfulfill the green energy demands of global ESG development.
Shifan Microelectronics — Shifan Microelectronics offers intelligent display SOC chip design and development services. Shifan Microelectronics is primarily concerned with the research and development of display processing and device technologies.

Jinding Capital is a leading industrial equity investment institution in China.

Investment focus

Manufacturing, Health Care, E-Commerce
Series A, Series B, Seed
China

Portfolio highlights

Robot era — Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes.
Jinjing Keji — Jinjing Keji manufactures cathode fluorescence system products. They are mainly in scientific research institutes, semiconductor industry, and electron microscope manufacturing. They provide testing services too in addition to selling the product.
Shengzhi Runhe — Shengzhi Runhe is a producer of medical and aesthetic regeneration materials. It is committed to being a technology innovator and primary service provider in the anti-aging field of regenerative biomaterials.

Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, Singapore, United States

Portfolio highlights

Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.
Hunan Yiyi Pharmaceutical Technology — Hunan Yiyi Pharmaceutical Technology

Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Seed
China, United States

Portfolio highlights

Fabrie — Fabrie develops collaboration tool for designers that has functions such as multi-person collaboration, table and diagram association, cloud storage and sharing.
Aiagain — Aiagain is the provider of an online WeChat management platform for WeChat sellers.
Fengtai Technology — Focusing on industrial information security, Fujian and Taiwan technology mainly provides professional, standard chemical control safety consulting and evaluation services to ensure information security of key industrial information infrastructure and improve security protection solutions. It mainly serves the government, industry customers, designinstitutes, research institutes, institutes, integrators and hardware and software manufacturers. Through visual, process and customized tools and methods, it helps users to carry out effective risk management and reliable operational support. .

SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.

Investment focus

Financial Services, Software, Information Technology
Series B, Funding Round, Series A
Japan, South Korea, United States

Portfolio highlights

Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
TopoLogic — TopoLogic designs and manufactures heat flow sensors, thermoelectric conversion devices, and topological and novel spintronics materials.
OPTEMO — OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Investment focus

Medical, Health Care, Biotechnology
Funding Round, Seed, Series A
Japan

Portfolio highlights

newmo — newmo delivers sustainable local public transportation create a user experience (UX) that people may utilize with peace of mind and comfort.
Axelspace — Axelspace is a startup company developing businesses in the microsatellite field. Axelspace plans to construct a monitoring platform to cover the entire globe on a daily basis at extremely low cost.
Hedgehog MedTech — Hedgehog Medtech is a medical firm focused on digital therapeutics (DTx). DTx is a pharmaceutically approved programmable medical device that assists patients' medical operations via smartphone apps.

Qingrong Ventures is an Investment firm.

Investment focus

Medical, Health Care, Medical Device
Angel
China

Portfolio highlights

BrainThink — BrainThink integrates wearable sensors to deliver scalp electroencephalogram (EEG) and heart rate variability (HRV). BrainThink provides fast assessment for depression, anxiety, motor imagery, and attention.
Yuansheng Intelligence — Yuansheng Intelligence is a manufacturer of intricate rehabilitation and nursing medical hardware.

Yuanhui Chuangyi is an investment firm.

Investment focus

Beauty, Industrial, Medical Device
Seed
China

Portfolio highlights

Toll PATEO — Toll PATEO is a natural science, medical research and experimental development service provider.
Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
Xijian Technology — Xijian Technology is committed to advancing the industrialization of innovative human biomechanics imaging technology. It focuses on health disciplines such as sports rehabilitation, dermatology and beauty, and disease diagnosis and treatment.

BGI Co-Win is the corporate venture capital arm of BGI and is based in Shenzhen, China.

Investment focus

Biotechnology, Health Care, Biopharma
Seed, Series A, Angel
China

Portfolio highlights

LeadBio Tech — LeadBio Tech is a biotechnology company that specializes in the development of bioartificial blood vessel medical devices.
Yingshu Life — Yingshu Life is a research and development manufacturer of minimally invasive medical devices.
Waker Biology — Weike Bio is a gene therapy drug development company.

Redhill Capital is a venture capital firm specializing in early stage investment. It primary invests in medical industry.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Angel
China

Portfolio highlights

Douli — Douli is an employee service platform that provides welfare solutions for enterprises. They offer services in the fields of clothing, food, housing, transportation, medical care, entertainment, and more by combining online and offline multi-channel resources.
Inflamax Pharmaceuticals — Inflamax Pharmaceuticals is a biomedical technology company that specializes in the innovation and development of immune-inflammatory drugs.
EnCureGen Pharmaceuticals — Huizhengqi Medicine is a pharmaceutical company that develops mRNA drugs for the treatment of tumor and immunity diseases.

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Turno — Turno Finance makes owning EV very affordable. Turno Club is a community around commercial EVs. Turno Battery Future is our solution to keeping batteries on the road for longer.
Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
Huayuan Regenerative Medicine — Huayuan Regenerative Medicine is a developer of implantable biological artificial organs.

Insight Capital is a venture capital firm focused on early-stage investment.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series C, Series B
China

Portfolio highlights

LeadBio Tech — LeadBio Tech is a biotechnology company that specializes in the development of bioartificial blood vessel medical devices.
Yaoshi Medical — Yaoshi Medical conducts research and development in the field of ocular illness diagnosis and screening equipment.
Phil Rivers Technology — Zheyuan Technology is an AI pharmaceutical R&D solution provider.

Prosperico Ventures is a venture capital firm focused on healthcare and the high-tech industry.

Investment focus

Medical, Health Care, Biotechnology
Series A, Series B, Seed
China, United States

Portfolio highlights

Cytocares — Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.
KingstronBio — KingstronBio manufactures artificial heart valves and annuloplasty rings.
Jiaohong Biology — Jiaohong Biology is a molecular diagnostic technology research and development and application service provider.

Founded in 2014, Source Code Capital is a leading China VC focused on the broad TMT sectors and investing in both early stage start-ups and growth stage companies. With $1.5 billion and RMB 3.5 billion under management, Source Code Capital has been successfully partnering with close to 150 leading Chinese technology founders since inceptionincluding Bytedance, Meituan, Homelink, among many others. Source Code is focused on the “Big 3” fundamental drivers, which are Internet+, AI+, and Global+ , and invests along sectors such as media and entertainment, consumer services, enterprise, finance, retail, transportation, housing, education, and healthcare.

Investment focus

Software, E-Commerce, Artificial Intelligence
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

Powerlaw AI — Powerlaw Ai is a developer of artificial intelligence technology designed to improve the efficiency of legal processes.
Unitree Robotics — Unitree focus on the development of four-legged robot mobile platform and related power system components
Erui Micro Semiconductor — Erui Micro Semiconductor is a semiconductor company that specializes in the development of semiconductor overlay front-end measurement equipment.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Angel
China, United States, Hong Kong

Portfolio highlights

Leo Summit — Leo Summit is positioned as a provider of life science laboratory automation solutions. It provides reliable and flexible solutions for the biomedical industry, driven by the demand for automated intelligent technology in clinical medicine and drug R&D industries, and relies on artificial intelligence and motion control technology. Providesystematic intelligent products and solutions for R&D firms, AI pharmaceuticals, and CRO firms in the fields of new medications, synthetic biology, and single-cell sequencing.
Leaf Biotech — Leaf Biotech is a research and development, production and sales of green chemical-related materials and series intermediates. The business produces biomass resources. The focus of the research and development is the bio-based polyester material PEF and important intermediates, as well as the creation of green drugs and intermediates for healthcareproducts.
Bowang Pharmaceutical — Bowang Pharmaceutical is an RNAi drug research and development platform focused on siRNA drug development.